Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. Raw material testing to account for the largest share of the bioburden testing applications market Based on application, the  bioburden testing market  is segmented into raw material testing, medical device testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The raw material testing segment is expected to account for the largest market share in 2018. The large share of this segment can be attributed to the rising quality standards in manufacturing to avoid consequences such as contaminations and break

The  interventional radiology products market  is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. This market is segmented based on type, procedure, application, and region. The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology sector face significant entry barriers; this is a key challenge in the market. Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the

The overall  biosurgery market  is expected to grow from USD 10.67 billion in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 15.58 billion by 2023. The rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities, and growing need for effective blood loss management in patients which, in turn, help in the growth of the market. The biosurgery market is expanding with the emergence of new products and applications. These biosurgery product being used in many applications such gynecological surgery, general surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, urological surgery, reconstructive surgery and thoracic surgery. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023. The reconstructive surgeries segment is expected to register the hig

The global  plastic surgery instruments market  is expected to reach USD 1,479.0 Million by 2023 from USD 1,002.0 Million in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers of the global plastic surgery instruments market. This market is segmented on the basis of type, procedure, end user, and region. By type, the market is segmented into handheld instruments, electrosurgical instruments, and other plastic surgery instruments. In 2018, the handheld instruments segment is expected to account for the largest share of the market. The large share of this segment is attributed to factors such as increasing number of plastic surgeries and the wide range of uses of handheld instruments in almost all types of plastic surgical procedures. Based on procedure, the plastic surgery instruments market is segmented into cosmetic surgery and reconstruc

Increasing adoption of 3D cell culture technique in drug discovery is fueling the growth of 3D cell culture market Globally, the 3D cell culture market is witnessing high growth due to factors such as rise in research and development investments, higher adoption, use of microfluidic technology, increasing focus on regenerative medicine, and use of 3D cell culture models for drug discovery and toxicology in vivo testing. In addition, rapid increase in the need for organ transplantation is further expected to propel the growth of this market in coming years. However, the budget restraints by laboratories, lack of experienced professionals, and lack of consistency in 3D cell culture products, cost and complexity, and ethical concerns using animal sources are affecting the growth of this market. Based on technology, the 3D cell culture market is segmented into scaffold-based and scaffold free systems. The scaffold-based segment is expected to account for the largest share of the glob

Specific diagnostic imaging devices are utilized in hybrid operating room settings to address the procedural requirements of healthcare professionals, such as real-time imaging of cardiac anatomies during CVD treatment, advanced brain mapping during cerebrovascular surgery, and orthopedic imaging during accidental trauma management. The major diagnostic modalities utilized in hybrid OR workflows include angiography systems, computed tomography (CT) scanners, and magnetic resonance imaging (MRI) systems. Growth in this market segment can be attributed to factors such as significant installation costs associated with diagnostic imaging products, increasing installation of hybrid ORs across major countries, ongoing integration and automation of OR workflows, and continuous technological advancements in the field of diagnostic imaging. The global  hybrid operating room market  is segmented by component, application, end user and region. Based on component, the hybrid operating rooms ma

The  blood group typing market  is consolidated in nature due to the presence of a few large players. The prominent players in the market are Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France). Bio-Rad Laboratories, Inc. was the largest player in the market in 2015 with its strong product portfolio for blood group typing. The company focuses on acquisitions to strengthen its position in the market. For instance, in February 2015, Bio-Rad Laboratories acquired GnuBIO Inc. (U.S.). This acquisition helped the company to expand its blood group typing portfolio. Such acquisitions enabled the company to increase its product portfolio in the market. The company is also focused on expansion activities to increase its global presence. Ortho Clinical Dia

The  fluid management visualization systems market  is projected to reach USD 12.47 Billion by 2021 from USD 9.39 Billion in 2016, at a CAGR of 5.8% during the forecast period. Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management system, and increase in government funds and grants worldwide for endosurgical procedures are driving the market. Geographically, the global fluid management visualization systems market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America, comprising the U.S. and Canada, accounted for the largest share of the global market in 2015. The large share of this region can be attributed to the growth in aging and chronically ill population, increasing number of minimally invasive surgeries, growth in the number of dialysis centers, rising usage of single-use disposable accessories, and advancements in technologies. Moreover, considering the increasing prevalen

The global  enteral feeding formulas market  is projected to reach USD 5.95 Billion by 2020, at a CAGR of 7.6% from 2015 to 2020. The enteral feeding formulas market witnessed substantial growth in the past few years, which had a positive impact on the overall growth of the market. The global enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent. On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-

The  neuroendoscopy market  is expected to reach USD 218.9 million by 2022 from USD 163.9 million in 2016, at a CAGR of 5.1% during the forecast period. Factors such as favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. However, the high cost of neuroendoscopy procedures and equipment may hinder the growth of the market. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. Market Dynamics Drivers Favorable Government Initiatives Rising Prevalence of Neurological Disorders Benefits of Neuroendoscopic Surgery Over Conventional Brain Surgery Restraints High Cost of Neuroendoscopy Procedures & Equipment Opportunities Growing Healthcare Market in Emerging Economies Challenges Dearth of Trained Neurologists and Endoscopists Rising prevalence of neurological disorders to drive

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The successful

The  Angiographic Catheters Market  is expected to reach USD 1,402.8 million by 2022 from USD 980.9 million in 2017, at a CAGR of 7.4%. Market growth is primarily driven by the aging population and increasing incidence of diseases such as CVDs; and demand for angiographic catheter for the diagnosis of arterial blockages. Technological advancements in catheter-based angiography techniques is driving growth of this market. The global market is dominated by Europe, followed by Asia Pacific. Europe will continue to dominate the market during the forecast period mainly due to the presence of large patient population. However, Asia Pacific is expected to witness the highest CAGR. Factors such as the increasing burden of coronary arterial disease and focus of major players in emerging Asia Pacific countries are driving the growth of the market in this region. However, increasing preference for non-invasive angiography is expected to hinder the growth of market. Additionally, increasing nu

The global  molecular spectroscopy market  is projected to be valued at USD 4.68 Billion in 2016 and is expected to grow at a CAGR of 6.6% to reach to USD 6.85 Billion by 2022. The growth of the overall molecular spectroscopy market can be attributed to the growing food safety concerns, the growth of the pharmaceutical and biotechnology industry, application of molecular spectroscopy in environmental screening and technological advancements in molecular spectroscopy. In the coming years, North America is expected to account for the largest share of the global molecular spectroscopy market. Molecular Spectroscopy Market, by Application Pharmaceutical Applications Biotechnology & Biopharmaceutical Applications Food & Beverage Testing Environment Testing Academic Research Based on application, the molecular spectroscopy market is segmented into pharmaceutical application, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application

Mass spectrometry is an analytical technique used to measure known materials, to identify unknown compounds within a sample, and to evaluate the structure and chemical properties of different molecules. The technique ionizes chemical species and sorts the ions, based on their mass-to-charge ratio. Because of the high sensitivity of these techniques, mass spectroscopy has become a powerful analytical tool for testing in various industries. Factors such as technological advancements in mass spectrometry, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, growing petrochemical industry, and growing focus on ensuring the quality of food products are expected to drive the growth of  Mass Spectrometry Market . Major Market Developments In 2017, Thermo Fisher Scientific launched the Cascadion SM Clinical Analyzer, the ISQ EC Single Quadrupole Mass Spectrometer, and Q Exactive HF-X Mass Spectrometer, t

“ Mass Spectrometry Market   by Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) – Global Forecast to 2022 “,  published by MarketsandMarkets™, the market is expected to reach USD 5.27 Billion by 2022 from an estimated USD 3.68 Billion in 2017, at a CAGR of 7.4%. The key factors which include the growth of the mass spectrometry market are pharmaceutical and biotechnology industry and technological advancements in mass spectrometry. The growing use of mass spectrometry in emerging markets and the rising potential for the application of high-resolution mass spectrometry in healthcare are the key areas of opportunity in this market. Based on application, the Mass Spectrometry Market is further segmented into pharmaceutical application, biotech application, environmental testing, food and beverage testing, petrochemical applications,